SEC 13F Intelligence

Lone Peak Global Investors LLC / GSK

Lone Peak Global Investors LLC’s Gsk PLC Position

Does Lone Peak Global Investors LLC own Gsk PLC (GSK)? Not currently — the last reported position was 409.7K shares worth $17M in Q3 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$17M
Q3 2024
Shares
409.7K
% of Portfolio
+3.34%
Quarters Held
8
position exited

Position History GSK

Reported value by quarter
Q3 ’22: $6MQ3 ’22Q4 ’22: $9MQ4 ’22Q1 ’23: $9MQ1 ’23Q2 ’23: $9MQ2 ’23Q3 ’23: $10MQ3 ’23Q4 ’23: $11MQ4 ’23Q1 ’24: $13MQ1 ’24Q3 ’24: $17MQ3 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2024409.7K$17M+3.34%
Q1 2024295.3K$13M+3.21%
Q4 2023287.2K$11M+2.75%
Q3 2023280.2K$10M+2.96%
Q2 2023266.3K$9M+2.74%
Q1 2023266.8K$9M+2.92%
Q4 2022262.0K$9M+2.80%
Q3 2022202.3K$6M+2.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lone Peak Global Investors LLC’s full portfolio or all institutional holders of GSK.